| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.955 | 0.001 | 0.99 | DNA synthesis inhibitor | 0.99 0.001 DBMET00419 | DBMET00419 | |
| 0.92 | 0.001 | 0.92 | Adenosine A1 receptor antagonist | 0.692 0.002 DBMET00419 | ||
| 0.898 | 0.004 | 0.898 | Immunomodulator | 0.882 0.004 DBMET00419 | ||
| 0.879 | 0.001 | 0.879 | Adenosine A2a receptor antagonist | 0.499 0.003 DBMET00419 | ||
| 0.873 | 0.001 | 0.969 | RNA-directed DNA polymerase inhibitor | 0.969 0 DBMET00419 | DBMET00419 | |
| 0.84 | 0.001 | 0.84 | Adenosine A2 receptor antagonist | 0.44 0.004 DBMET00419 | ||
| 0.827 | 0.001 | 0.9 | DNA repair enzyme inhibitor | 0.9 0.001 DBMET00419 | DBMET00419 | |
| 0.774 | 0.001 | 0.915 | Antimetabolite | 0.915 0.001 DBMET00419 | DBMET00419 | |
| 0.767 | 0.001 | 0.767 | Adenosine A1 receptor agonist | 0.614 0.002 DBMET00419 | ||
| 0.742 | 0.002 | 0.742 | DNA methylase inhibitor | 0.74 0.002 DBMET00419 | ||
| 0.647 | 0.003 | 0.726 | Adenylate cyclase inhibitor | 0.726 0.001 DBMET00419 | DBMET00419 | |
| 0.63 | 0.002 | 0.764 | NADH dehydrogenase inhibitor | 0.764 0.001 DBMET00419 | DBMET00419 | |
| 0.622 | 0.001 | 0.891 | Ribonucleotide reductase inhibitor | 0.891 0.001 DBMET00419 | DBMET00419 | |
| 0.61 | 0.004 | 0.61 | DNA methyltransferase I inhibitor | 0.162 0.092 DBMET00419 | ||
| 0.604 | 0.002 | 0.604 | Adenosine A3 receptor antagonist | 0.285 0.006 DBMET00419 | ||
| 0.566 | 0.005 | 0.566 | Cyclic AMP phosphodiesterase inhibitor | 0.363 0.023 DBMET00419 | ||
| 0.551 | 0.002 | 0.811 | Ribonucleoside-diphosphate reductase inhibitor | 0.811 0.001 DBMET00419 | DBMET00419 | |
| 0.558 | 0.019 | 0.62 | Immunosuppressant | 0.62 0.011 DBMET00419 | DBMET00419 | |
| 0.538 | 0.002 | 0.538 | Adenosine A2b receptor agonist | 0.173 0.002 DBMET00419 | ||
| 0.585 | 0.057 | 0.585 | Antiinflammatory | 0.409 0.134 DBMET00419 | ||
| 0.517 | 0.001 | 0.517 | Adenosine A3 receptor agonist | 0.307 0.002 DBMET00419 | ||
| 0.497 | 0.002 | 0.798 | Thymidine kinase inhibitor | 0.798 0.001 DBMET00419 | DBMET00419 | |
| 0.498 | 0.004 | 0.616 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.616 0.002 DBMET00419 | DBMET00419 | |
| 0.487 | 0.003 | 0.587 | UDP-glucose 4-epimerase inhibitor | 0.587 0.001 DBMET00419 | DBMET00419 | |
| 0.474 | 0.003 | 0.692 | Carbamoyl phosphate synthetase inhibitor | 0.692 0.001 DBMET00419 | DBMET00419 | |
| 0.405 | 0.001 | 0.405 | Adenosine deaminase inhibitor | 0.342 0.001 DBMET00419 | ||
| 0.458 | 0.054 | 0.458 | Antibacterial | 0.43 0.064 DBMET00419 | ||
| 0.406 | 0.006 | 0.551 | DNA polymerase I inhibitor | 0.551 0.003 DBMET00419 | DBMET00419 | |
| 0.403 | 0.003 | 0.553 | Adenylate kinase inhibitor | 0.553 0.001 DBMET00419 | DBMET00419 | |
| 0.4 | 0.002 | 0.559 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.559 0.001 DBMET00419 | DBMET00419 | |
| 0.367 | 0.004 | 0.623 | Phosphofructokinase-1 inhibitor | 0.623 0.001 DBMET00419 | DBMET00419 | |
| 0.357 | 0.005 | 0.439 | Aminoacyl-tRNA synthetase inhibitor | 0.439 0.003 DBMET00419 | DBMET00419 | |
| 0.352 | 0.013 | 0.49 | Cytidine deaminase inhibitor | 0.49 0.006 DBMET00419 | DBMET00419 | |
| 0.388 | 0.053 | 0.499 | Immunostimulant | 0.499 0.029 DBMET00419 | DBMET00419 | |
| 0.372 | 0.047 | 0.372 | Apoptosis antagonist | 0.315 0.076 DBMET00419 | ||
| 0.311 | 0.003 | 0.64 | Purinergic P2Y antagonist | 0.64 0.001 DBMET00419 | DBMET00419 | |
| 0.306 | 0.002 | 0.486 | Phosphoglycerate kinase inhibitor | 0.486 0.001 DBMET00419 | DBMET00419 | |
| 0.406 | 0.111 | 0.412 | Apoptosis agonist | 0.412 0.108 DBMET00419 | DBMET00419 | |
| 0.333 | 0.038 | 0.333 | Angiogenesis stimulant | 0.292 0.052 DBMET00419 | ||
| 0.287 | 0.004 | 0.287 | Phosphodiesterase II inhibitor | 0.218 0.004 DBMET00419 | ||
| 0.286 | 0.013 | 0.667 | Aldehyde dehydrogenase inhibitor | 0.667 0.003 DBMET00419 | DBMET00419 | |
| 0.276 | 0.004 | 0.276 | Phosphodiesterase 2A inhibitor | 0.207 0.004 DBMET00419 | ||
| 0.33 | 0.066 | 0.33 | Vasodilator, coronary | 0.245 0.14 DBMET00419 | ||
| 0.261 | 0.001 | 0.261 | Adenosine A2 receptor agonist | 0.15 0.002 DBMET00419 | ||
| 0.262 | 0.005 | 0.262 | T cell inhibitor | 0.12 0.014 DBMET00419 | ||
| 0.297 | 0.041 | 0.297 | Anticonvulsant | 0.154 0.124 DBMET00419 | ||
| 0.302 | 0.056 | 0.302 | DNA damaging | 0.21 0.107 DBMET00419 | ||
| 0.244 | 0.003 | 0.319 | Acyl-CoA dehydrogenase inhibitor | 0.319 0.001 DBMET00419 | DBMET00419 | |
| 0.244 | 0.007 | 0.244 | CF transmembrane conductance regulator agonist | |||
| 0.241 | 0.008 | 0.733 | Glutamate dehydrogenase inhibitor | 0.733 0.002 DBMET00419 | DBMET00419 | |
| 0.236 | 0.004 | 0.501 | Biliverdin reductase inhibitor | 0.501 0.001 DBMET00419 | DBMET00419 | |
| 0.316 | 0.087 | 0.316 | Transcription factor NF kappa B inhibitor | 0.19 0.179 DBMET00419 | ||
| 0.23 | 0.006 | 0.539 | Argininosuccinate synthase inhibitor | 0.539 0.002 DBMET00419 | DBMET00419 | |
| 0.224 | 0.001 | 0.224 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.191 0.002 DBMET00419 | ||
| 0.221 | 0.001 | 0.411 | Purinergic P2X agonist | 0.411 0.001 DBMET00419 | DBMET00419 | |
| 0.293 | 0.082 | 0.293 | Caspase 3 stimulant | 0.21 0.155 DBMET00419 | ||
| 0.205 | 0.002 | 0.205 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.11 0.003 DBMET00419 | ||
| 0.191 | 0.001 | 0.191 | Adenosine A2a receptor agonist | 0.082 0.002 DBMET00419 | ||
| 0.204 | 0.013 | 0.312 | DNA directed RNA polymerase inhibitor | 0.312 0.006 DBMET00419 | DBMET00419 | |
| 0.285 | 0.105 | 0.285 | Vasodilator, peripheral | 0.225 0.149 DBMET00419 | ||
| 0.238 | 0.059 | 0.238 | Peptidyltransferase inhibitor | 0.172 0.144 DBMET00419 | ||
| 0.179 | 0.004 | 0.358 | Purinergic P2X1 antagonist | 0.358 0.001 DBMET00419 | DBMET00419 | |
| 0.156 | 0.001 | 0.25 | Purinergic P2Y1 agonist | 0.25 0 DBMET00419 | DBMET00419 | |
| 0.144 | 0.002 | 0.226 | Adenosine kinase inhibitor | 0.226 0.002 DBMET00419 | DBMET00419 | |
| 0.223 | 0.086 | 0.289 | Platelet antagonist | 0.289 0.056 DBMET00419 | DBMET00419 | |
| 0.263 | 0.137 | 0.263 | Toll-Like receptor agonist | |||
| 0.291 | 0.166 | 0.49 | DNA directed DNA polymerase inhibitor | 0.49 0.085 DBMET00419 | DBMET00419 | |
| 0.222 | 0.101 | 0.222 | Interleukin agonist | |||
| 0.133 | 0.013 | 0.133 | Interferon agonist | 0.102 0.027 DBMET00419 | ||
| 0.121 | 0.004 | 0.431 | Inosine monophosphate dehydrogenase inhibitor | 0.431 0.002 DBMET00419 | DBMET00419 | |
| 0.19 | 0.076 | 0.19 | Platelet adhesion inhibitor | 0.19 0.077 DBMET00419 | ||
| 0.115 | 0.004 | 0.218 | AICAR transformylase inhibitor | 0.218 0.002 DBMET00419 | DBMET00419 | |
| 0.113 | 0.005 | 0.687 | Fumarate hydratase inhibitor | 0.687 0.001 DBMET00419 | DBMET00419 | |
| 0.12 | 0.013 | 0.457 | Ornithine carbamoyltransferase inhibitor | 0.457 0.003 DBMET00419 | DBMET00419 | |
| 0.125 | 0.019 | 0.23 | Purinergic P2X2 antagonist | 0.23 0.004 DBMET00419 | DBMET00419 | |
| 0.114 | 0.008 | 0.114 | Interferon inducer | |||
| 0.112 | 0.009 | 0.112 | Adenosine A2b receptor antagonist | |||
| 0.25 | 0.148 | 0.25 | Toll-Like receptor 7 agonist | |||
| 0.104 | 0.002 | 0.104 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.024 0.008 DBMET00419 | ||
| 0.18 | 0.08 | 0.18 | Hepatoprotectant | |||
| 0.114 | 0.015 | 0.114 | Cyclin E1 inhibitor | |||
| 0.116 | 0.019 | 0.116 | Cyclin E inhibitor | |||
| 0.096 | 0.005 | 0.208 | Purinergic P2T antagonist | 0.208 0.004 DBMET00419 | DBMET00419 | |
| 0.146 | 0.056 | 0.227 | Heat shock protein 70 antagonist | 0.227 0.004 DBMET00419 | DBMET00419 | |
| 0.098 | 0.015 | 0.098 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.083 | 0.004 | 0.135 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.135 0.001 DBMET00419 | DBMET00419 | |
| 0.083 | 0.01 | 0.083 | Nicotinic acid receptor 1 agonist | |||
| 0.113 | 0.04 | 0.246 | Alcohol dehydrogenase inhibitor | 0.246 0.008 DBMET00419 | DBMET00419 | |
| 0.144 | 0.072 | 0.144 | Adenylate cyclase stimulant | 0.142 0.078 DBMET00419 | ||
| 0.069 | 0.003 | 0.243 | Purinergic P2Y1 antagonist | 0.243 0.002 DBMET00419 | DBMET00419 | |
| 0.07 | 0.007 | 0.255 | HCV NS5B polymerase inhibitor | 0.255 0.003 DBMET00419 | DBMET00419 | |
| 0.063 | 0.002 | 0.063 | Purinergic P2Y15 antagonist | 0.04 0.007 DBMET00419 | ||
| 0.061 | 0.004 | 0.314 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.314 0.001 DBMET00419 | DBMET00419 | |
| 0.058 | 0.005 | 0.193 | Purinergic P2Y12 antagonist | 0.193 0.004 DBMET00419 | DBMET00419 | |
| 0.055 | 0.002 | 0.055 | Isoleucine-tRNA ligase inhibitor | 0.03 0.005 DBMET00419 | ||
| 0.056 | 0.003 | 0.128 | Purinergic receptor agonist | 0.128 0.001 DBMET00419 | DBMET00419 | |
| 0.056 | 0.003 | 0.128 | Purinergic P2 agonist | 0.128 0.001 DBMET00419 | DBMET00419 | |
| 0.141 | 0.089 | 0.307 | Hexokinase inhibitor | 0.307 0.01 DBMET00419 | DBMET00419 | |
| 0.095 | 0.044 | 0.108 | Transcription factor NF kappa B stimulant | 0.108 0.033 DBMET00419 | DBMET00419 | |
| 0.056 | 0.01 | 0.056 | Antibiotic Aminoglycoside-like | 0.046 0.016 DBMET00419 | ||
| 0.073 | 0.027 | 0.073 | Transcription factor AP-1 inhibitor | |||
| 0.212 | 0.169 | 0.212 | Interleukin 2 agonist | |||
| 0.044 | 0.003 | 0.11 | Purinergic P2Y agonist | 0.11 0.001 DBMET00419 | DBMET00419 | |
| 0.04 | 0.001 | 0.274 | Purinergic P2Y2 agonist | 0.274 0 DBMET00419 | DBMET00419 | |
| 0.04 | 0.006 | 0.096 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.096 0.003 DBMET00419 | DBMET00419 | |
| 0.071 | 0.038 | 0.296 | Purinergic P2 antagonist | 0.296 0.005 DBMET00419 | DBMET00419 | |
| 0.045 | 0.013 | 0.139 | Purinergic P2Y2 antagonist | 0.139 0.003 DBMET00419 | DBMET00419 | |
| 0.061 | 0.03 | 0.061 | Protein 50S ribosomal subunit inhibitor | 0.06 0.031 DBMET00419 | ||
| 0.099 | 0.071 | 0.099 | Topoisomerase I inhibitor | |||
| 0.03 | 0.002 | 0.047 | Methylmalonyl-CoA mutase inhibitor | 0.047 0.001 DBMET00419 | DBMET00419 | |
| 0.036 | 0.008 | 0.036 | Thymidine phosphorylase inhibitor | 0.03 0.012 DBMET00419 | ||
| 0.061 | 0.035 | 0.062 | Lipocortins synthesis agonist | 0.062 0.031 DBMET00419 | DBMET00419 | |
| 0.048 | 0.03 | 0.108 | Thymidylate synthase inhibitor | 0.108 0.004 DBMET00419 | DBMET00419 | |
| 0.019 | 0.008 | 0.019 | O6-alkylguanine-DNA alkyltransferase inhibitor | |||
| 0.09 | 0.081 | 0.131 | Expectorant | 0.131 0.044 DBMET00419 | DBMET00419 | |
| 0.083 | 0.076 | 0.083 | Uric acid excretion stimulant | |||
| 0.013 | 0.006 | 0.016 | Purine nucleoside phosphorylase inhibitor | 0.016 0.004 DBMET00419 | DBMET00419 | |
| 0.091 | 0.085 | 0.091 | DNA intercalator | |||
| 0.182 | 0.176 | 0.182 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.155 | 0.15 | 0.197 | Vasodilator | 0.197 0.107 DBMET00419 | DBMET00419 | |
| 0.022 | 0.019 | 0.022 | Protein 30S ribosomal subunit inhibitor | |||
| 0.066 | 0.064 | 0.066 | Phosphodiesterase VIII inhibitor | |||
| 0.003 | 0.002 | 0.012 | Purinergic P2Y6 agonist | 0.012 0.001 DBMET00419 | DBMET00419 | |
| 0.002 | 0.006 | 0.009 | Purinergic P2Y4 agonist | 0.009 0.002 DBMET00419 | DBMET00419 | |
| 0.034 | 0.046 | 0.07 | Guanylate cyclase inhibitor | 0.07 0.005 DBMET00419 | DBMET00419 | |
| 0.106 | 0.138 | 0.135 | Insulin secretagoues | 0.135 0.091 DBMET00419 | DBMET00419 | |
| 0.188 | 0.233 | 0.267 | Calcium channel activator | 0.267 0.127 DBMET00419 | DBMET00419 | |
| 0.077 | 0.135 | 0.129 | Folate antagonist | 0.129 0.032 DBMET00419 | DBMET00419 | |
| 0.121 | 0.182 | 0.347 | Phospholipase C inhibitor | 0.347 0.014 DBMET00419 | DBMET00419 | |
| 0.038 | 0.101 | 0.111 | HIV-1 reverse transcriptase inhibitor | 0.111 0.025 DBMET00419 | DBMET00419 | |
| 0.044 | 0.112 | 0.132 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.132 0.025 DBMET00419 | DBMET00419 | |
| 0.019 | 0.097 | 0.043 | RNA-directed RNA polymerase inhibitor | 0.043 0.017 DBMET00419 | DBMET00419 | |
| 0.067 | 0.149 | 0.115 | Alkylator | 0.115 0.073 DBMET00419 | DBMET00419 | |
| 0.029 | 0.113 | 0.051 | Glucose-6-phosphate isomerase inhibitor | 0.051 0.029 DBMET00419 | DBMET00419 | |
| 0.017 | 0.118 | 0.046 | Phosphorylase inhibitor | 0.046 0.033 DBMET00419 | DBMET00419 | |
| 0.054 | 0.168 | 0.13 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.13 0.034 DBMET00419 | DBMET00419 | |
| 0.023 | 0.181 | 0.087 | Purinergic P2X4 antagonist | 0.087 0.005 DBMET00419 | DBMET00419 | |
| 0.042 | 0.251 | 0.086 | Triose-phosphate isomerase inhibitor | 0.086 0.066 DBMET00419 | DBMET00419 | |
| 0.049 | 0.265 | 0.098 | Toll-Like receptor 4 antagonist | 0.098 0.073 DBMET00419 | DBMET00419 | |
| 0.001 | 0.23 | 0.012 | Mannitol 2-dehydrogenase inhibitor | 0.012 0.004 DBMET00419 | DBMET00419 | |
| 0.024 | 0.291 | 0.056 | Antiviral (Hepatitis D) | 0.056 0.027 DBMET00419 | DBMET00419 | |
| 0.013 | 0.336 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.01 DBMET00419 | DBMET00419 | |
| 0.046 | 0.392 | 0.153 | Antimitotic | 0.153 0.119 DBMET00419 | DBMET00419 | |
| 0.025 | 0.959 | 0.121 | Sphingosine 1-phosphate receptor 2 agonist | 0.121 0.053 DBMET00419 | DBMET00419 | |
| 0.001 | 0.993 | 0.041 | Sphingosine 1-phosphate receptor 3 agonist | 0.041 0.021 DBMET00419 | DBMET00419 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |